500 related articles for article (PubMed ID: 22499993)
1. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.
Gonçalves I; Edsfeldt A; Ko NY; Grufman H; Berg K; Björkbacka H; Nitulescu M; Persson A; Nilsson M; Prehn C; Adamski J; Nilsson J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1505-12. PubMed ID: 22499993
[TBL] [Abstract][Full Text] [Related]
2. Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques.
Asciutto G; Edsfeldt A; Dias NV; Nilsson J; Prehn C; Adamski J; Gonçalves I
Cardiovasc Pathol; 2013; 22(6):438-43. PubMed ID: 23747086
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
Mannheim D; Herrmann J; Versari D; Gössl M; Meyer FB; McConnell JP; Lerman LO; Lerman A
Stroke; 2008 May; 39(5):1448-55. PubMed ID: 18356547
[TBL] [Abstract][Full Text] [Related]
4. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
5. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
6. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques].
Bonnefont-Rousselot D
Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399
[TBL] [Abstract][Full Text] [Related]
7. Carotid Plaque Inflammation Assessed by
Bueno A; March JR; Garcia P; Cañibano C; Ferruelo A; Fernandez-Casado JL
Angiology; 2021 Mar; 72(3):260-267. PubMed ID: 33089697
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
[TBL] [Abstract][Full Text] [Related]
9. [Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].
Zhang W; Zhang YM; Li LL; Xia Y; Zhou X; Zhu XQ; Sun ZW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1130-1135. PubMed ID: 32311875
[No Abstract] [Full Text] [Related]
10. Utility of Lp-PLA2 in lipid-lowering therapy.
Racherla S; Arora R
Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
[TBL] [Abstract][Full Text] [Related]
11. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
Shi Y; Zhang P; Zhang L; Osman H; Mohler ER; Macphee C; Zalewski A; Postle A; Wilensky RL
Atherosclerosis; 2007 Mar; 191(1):54-62. PubMed ID: 16765356
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice.
Wang WY; Zhang J; Wu WY; Li J; Ma YL; Chen WH; Yan H; Wang K; Xu WW; Shen JH; Wang YP
PLoS One; 2011; 6(8):e23425. PubMed ID: 21909350
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein associated phospholipase A2].
Rubinstein A; Izkhakov E
Harefuah; 2011 Feb; 150(2):136-40, 205. PubMed ID: 22164942
[TBL] [Abstract][Full Text] [Related]
14. LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 AS A MARKER OF VULNERABLE ATHEROSCLEROTIC PLAQUE IN PATIENTS WITH INTERNAL CAROTID ARTERY STENOSIS.
Štefanič P; Kopolovets I; Hertelyová Z; Tóth Š; Frankovičová M
Georgian Med News; 2017 Jun; (267):27-34. PubMed ID: 28726649
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL induces procoagulant profiles by increasing lysophosphatidylcholine levels, lysophosphatidylethanolamine levels, and Lp-PLA
Kim M; Yoo HJ; Lee D; Lee JH
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1137-1146. PubMed ID: 32456947
[TBL] [Abstract][Full Text] [Related]
16. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.
Edsfeldt A; Nitulescu M; Grufman H; Grönberg C; Persson A; Nilsson M; Persson M; Björkbacka H; Gonçalves I
Stroke; 2012 Dec; 43(12):3305-12. PubMed ID: 23150653
[TBL] [Abstract][Full Text] [Related]
17. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
20. Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque.
Sarlon-Bartoli G; Boudes A; Buffat C; Bartoli MA; Piercecchi-Marti MD; Sarlon E; Arnaud L; Bennis Y; Thevenin B; Squarcioni C; Nicoli F; Dignat-George F; Sabatier F; Magnan PE;
Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):154-9. PubMed ID: 22075154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
